Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.57 |
| ▸ | EGFR | P00533 | 3/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | DDO | Q99489 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11897339 | 0.81 | EGFR (0.55) | AHREGFRCHRNA7ALDH1A1HSD17B10 | |
| SCHEMBL8087761 | 0.78 | CHRNA7 (0.46) | AHREGFRCHRNA7ALDH1A1HSD17B10 | |
| SCHEMBL7195762 | 0.75 | AHR (0.70) | AHRDAODDOALDH1A1HSD17B10 | |
| SCHEMBL30740647 | 0.74 | AHR (0.61) | AHRDAODDOALDH1A1HSD17B10 | |
| SCHEMBL4980225 | 0.74 | AHR (0.61) | AHRDAODDOALDH1A1HSD17B10 | |
| SCHEMBL22802322 | 0.73 | AHR (0.46) | AHREGFRDAODDOALDH1A1 | |
| SCHEMBL29649107 | 0.73 | AHR (0.44) | AHREGFRCHRNA7ALDH1A1HSD17B10 | |
| SCHEMBL154593 | 0.73 | AHR (1.00) | AHRDAODDOALDH1A1HSD17B10 | |
| SCHEMBL29420757 | 0.73 | AHR (1.00) | AHRDAODDOALDH1A1HSD17B10 | |
| SCHEMBL5730262 | 0.71 | MAPT (0.62) | AHRALDH1A1HSD17B10GPR3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569452-B2 | Preparation of phalloidin and its derivatives | AMERICAN PEPTIDE COMPANY, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-8569452-B2 | Preparation of phalloidin and its derivatives | AMERICAN PEPTIDE COMPANY, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20120214968-A1 | Preparation of phalloidin and its derivatives | BACHEM AMERICAS, INC. | 2012-08-23 | — | — | US | disclosed |
| US-20120214968-A1 | Preparation of phalloidin and its derivatives | BACHEM AMERICAS, INC. | 2012-08-23 | — | — | US | disclosed |
| US-20070275886-A1 | Phalloidin derivatives and methods for their synthesis | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2007-11-29 | — | — | US | disclosed |
| EP-0555537-B1 | Endothelin antagonists | BANYU PHARMA CO LTD (JP) | 2000-11-02 | — | — | EP | disclosed |
| US-5496928-A | Endothelin antagonistic substance | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1996-03-05 | — | — | US | disclosed |
| EP-0555537-A2 | Endothelin antagonistic substance | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214968-A1 | Preparation of phalloidin and its derivatives | ACTB, ACTR3, ACTR5 | AHR 4001/4885EGFR 3640/4885CHRNA7 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.